Beckman, Robert A.
Article History
Received: 15 April 2024
Accepted: 5 September 2024
First Online: 2 October 2024
Competing interests
: RAB is the Chief Scientific Officer of Onco-Mind, LLC, which holds patents on dynamic precision medicine, a novel approach to precision cancer medicine. He is uncompensated in this role and does not anticipate any patent royalties at this time. RAB has also recently consulted for AstraZeneca and Boehringer-Ingelheim in the area of oncology clinical trial design.